MELBOURNE, Australia, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology...
Sale Marks Milestone for Company's Commercial expansion at leading Center of ExcellenceWestport, CT, Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioSig...
CAMBRIDGE, Mass., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing...
THE WOODLANDS, Texas, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that it has received...
FRAMINGHAM, Mass., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel...
Figure 1 Remaining Lifetime Risk for ATM PV Carriers SALT LAKE CITY, Dec. 11, 2020 (GLOBE NEWSWIRE) -- In a...
THC Therapeutics, Inc. (THCT), a forward-thinking publicly traded technology company whose mission statement is "Better Health through the Science of...
RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company...
GAITHERSBURG, Md., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr....
NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based...
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES,...
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and...
PRESS RELEASE, Lund Sweden, December 11, 2020 - Active Biotech (NASDAQ STOCKHOLM: ACTI)Active Biotech AB (publ) today announce a...
ALLSCHWIL, Switzerland, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Polyphor AG (SIX: POLN) today announced the extension of its existing grant...
DXS INTERNATIONAL PLC Notification of Director / PDMR Dealing The Board of DXS International plc (the “Company”), the AQSE Growth...
First Pan-European consortium for future wind farm December 11, 2020 Consortium supports the development of additional 126 Megawatt capacity at...
Marseille, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Innate will no longer pursue Lumoxiti commercialization activities in US or EU; Company...
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in the...
Innate will no longer pursue Lumoxiti commercialization activities in US or EU; Company to re-focus investments in its R&D portfolio Companies...
Press ReleaseNicox’s Partner Fera Pharmaceuticals to Investigate Naproxcinod as Potential Covid-19 Adjuvant Treatment December 11, 2020 – release at 7:30...